443776-49-6

Basic information

• Product Name: BC 11 hydrobroMide
• Synonyms: BC 11 hydrobroMide
• CAS NO: 443776-49-6
• Molecular Formula: C8H12BBrN2O2S
• Molecular Weight: 290.97308
• Mol File: 443776-49-6.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: Hygroscopic, Refrigerator, Under inert atmosphere
• Solubility: Aqueous Base (Slightly), DMSO (Slightly), Water (Slightly)
• Stability: Hygroscopic
• CAS DataBase Reference: BC 11 hydrobroMide(CAS DataBase Reference)
• NIST Chemistry Reference: BC 11 hydrobroMide(443776-49-6)
• EPA Substance Registry System: BC 11 hydrobroMide(443776-49-6)

Safety Data

• Hazardous Substances Data: 443776-49-6(Hazardous Substances Data)

Usage

Description

BC 11 Hydrobromide is a selective urokinase (uPA) inhibitor, which is a compound that plays a crucial role in the regulation of blood clotting and fibrinolysis. It is characterized by its ability to inhibit clot lysis without affecting clot formation, making it a potential candidate for the development of therapeutic agents in various medical applications.

Uses

Used in Pharmaceutical Industry:
BC 11 Hydrobromide is used as a selective urokinase (uPA) inhibitor for its potential therapeutic applications in treating conditions related to blood clotting and fibrinolysis. Its ability to inhibit clot lysis without affecting clot formation makes it a promising candidate for the development of drugs that can help regulate blood clotting processes and prevent complications associated with clot formation or dissolution.
Used in Oncology Research:
BC 11 Hydrobromide is used as an anticancer agent for its ability to decrease the viability of MDA-MB231 breast cancer cells in vitro. This suggests that it may have potential applications in the development of targeted therapies for breast cancer and other malignancies, where selective inhibition of urokinase (uPA) can help limit tumor growth and metastasis.